Keyphrases
Activity-dependent Neuroprotective Protein
18%
Alcohol
100%
Alcohol Abuse
29%
Alcohol Addiction
28%
Alcohol Consumption
73%
Alcohol Drinking
44%
Alcohol Intake
29%
Alcohol Reward
27%
Alcohol Seeking
28%
Alcohol Use Disorder
51%
Alcohol Use Disorder Treatment
18%
Amphetamine
21%
Antipsychotic Efficacy
18%
Antipsychotics
36%
Brain-derived Neurotrophic Factor
18%
Cognitive Enhancer
19%
Conditioned Place Preference
15%
Counterconditioning
27%
Dorsolateral Striatum
20%
Ethanol
19%
Ethanol Intake
19%
Excessive Drinking
58%
Factor Level
15%
FGF receptor-1
16%
Fibroblast Growth factor-2 (FGF-2)
69%
Glial Cell Line-derived Neurotrophic Factor
70%
Growth Factors
16%
Inhibition Model
15%
Latent Inhibition
80%
Mammalian Target of Rapamycin (mTOR)
23%
Memory Reconsolidation
42%
Memory Retrieval
38%
Mesolimbic Dopamine System
18%
Mesolimbic System
16%
MK-801
15%
Neuroadaptation
40%
Nicotine
19%
Nucleus Accumbens
36%
Positive Symptoms
15%
Procognitive
19%
Promoter Expression
18%
Promoter Methylation
18%
Reconsolidation
37%
Relapse Prevention
14%
Responsive Genes
18%
Rodents
32%
Schizophrenia
55%
Scopolamine
44%
Two-bottle Choice
16%
Ventral Tegmental Area
50%
Neuroscience
Acetylcholinesterase Inhibitor
9%
Agonist
18%
Alcohol Abuse
69%
Antipsychotic
28%
Autoregulation
9%
Basic Fibroblast Growth Factor
65%
Basolateral Amygdala
9%
Behavior (Neuroscience)
48%
Brain-Derived Neurotrophic Factor
31%
Cholinergic
15%
Chromatin Assembly and Disassembly
9%
Cognitive Disorders
24%
Conditioned Place Preference
33%
Dementia Praecox
73%
DNA Methylation
10%
Dopaminergic
31%
Dopaminergic Neuron
13%
Drinking Behavior
20%
Enhancer Region
28%
Ethanol Metabolism
10%
Fibroblast Growth Factor Receptor 1
18%
Glial Cell Line-Derived Neurotrophic Factor
65%
Glial Cells
19%
Growth Factor
17%
Hippocampus
10%
Kinase
12%
Latent Inhibition
80%
Levoamphetamine
20%
Lithium Chloride
9%
Magnetic Resonance Imaging
9%
Mammalian Target of Rapamycin Complex 1
17%
Memory Reconsolidation
73%
Methylation
18%
NADH Dehydrogenase (Ubiquinone)
9%
Neuromodulation
9%
Neuroprotective Agent
9%
Neurotrophic Factor
20%
Nucleus Accumbens
35%
Phosphoinositide 3-Kinase
12%
Physical Dependence
11%
Physostigmine
12%
Prefrontal Cortex
12%
Promoter Region
20%
Protein Kinase Lyn
9%
Relapse Prevention
37%
Reward System
11%
Scopolamine
44%
Striatum
21%
Typical Antipsychotic
37%
Ventral Tegmental Area
55%